Call Price Match. Browse: Item 7 of Enroll for Auto-Ship and save time. Auto-Ship Requirements: Online account. A physical shipping address. PO Box address excluded. Prescription items require your pet's information and vet's information be setup in Your Account. Swine Pract. Paton D. Wensvoort G. Mystery swine disease in The Netherlands: The isolation of Lelystad virus. Collins J. Isolation of swine infertility and respiratory syndrome virus isolate ATCC VR in North American and experimental reproduction of the disease in gnotobiotic pigs.
Adams M. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses Arch. Cavanagh D. Nidovirales: A new order comprising Coronaviridae and Arteriviridae. Kuhn J. Reorganization and expansion of the nidoviral family Arteriviridae. Zimmerman J. Kimman T. Renukaradhya G.
Live porcine reproductive and respiratory syndrome virus vaccines: Current status and future direction. Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: Current status and future direction.
Charerntantanakul W. Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and satefy aspect. World J. Murtaugh M. Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome PRRS Vaccine. Bitsouni V. Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infection in pigs. Labarque G. Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs.
Karniychuk U. Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate. BMC Vet. Han K. Comparison of the virulence of European and North American genotypes of porcine reproductive and respiratory syndrome virus in experimentally infected pigs.
Pathogenesis of Korean type 1 European genotype porcine reproductive and respiratory syndrome virus in experimentally infected pigs.
Johnson W. Pathogenic and humoral immune responses to porcine reproductive and respiratory syndrome virus PRRSV are related to viral load in acute infection. Nelson E. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome PRRS virus.
Mateu E. The challenge of PRRS immunology. Lopez O. Course of PRRS immune reaction and adaptive immune response. Park C. Mengeling W. Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome virus. Hou F. Evaluation of a type 2 modified live porcine reproductive and respiratory syndrome vaccine against heterologous challenge of a lineage 3 highly virulent isolate in pigs.
Lager K. Bautista E. IFN gamma inhibits porcine reproductive and respiratory syndrome virus replication in macrophages. Rowland R. Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine. Loving C. Innate and adaptive immunity against porcine reproductive and respiratory syndrome virus. Lunney J. Trus I. Bonckaert C. Health Manag.
Renson P. Preparation for emergence of an Eastern European porcine reproductive and respiratory syndrome virus PRRSV strain in Western Europe: Immunization with modified live virus vaccines or a field strain confers partial protection. Canelli E. Phenotypic characterization of a highly pathogenic Italian porcine reproductive and respiratory syndrome virus PRRSV type 1 subtype 1 isolate in experimentally infected pigs. Frydas I. Replication characteristics of eight virulent and two attenuated genotype 1 and 2 porcine reproductive and respiratory syndrome virus PRRSV strains in nasal mucosa explants.
Kim T. Comparison of two commercial type 1 porcine reproductive and respiratory syndrome virus PRRSV modified live vaccines against heterologous type 1 and type 2 PRRSV challenge in growing pigs. Vaccine Immunol. Diaz I. Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. Van Woensel P. Martelli P. Efficacy of a modified live porcine reproductive and respiratory syndrome virus PRRSV vaccine in pigs naturally exposed to a heterologous European Italian cluster field strain: Clinical protection and cell-mediated immunity.
Canellia E. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 HP-PRRSV-1 Vet. Balka G. Genetic diversity of porcine reproductive and respiratory syndrome virus strains circulating in Hungarian swine herds.
Greiser-Wilke I. Papatsiros V. Viral Immunol. Roca M. Effect of challenge with a virulent genotype II strain of porcine reproductive and respiratoiry syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine. Savard C. Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.
Jeong J. Chand R. Pathogenesis of porcine reproductive and respiratory syndrome virus. Calvert J. Vaccination against porcine reproductive and respiratory syndrome virus PRRSV reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain. Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China.
Tian K. Tong G. Highly pathogenic porcine reproductive and respiratory syndrome, China. Van der Linden I. Virological kinetics and immunological responses to a porcine reproductive and respiratory syndrome virus infection of pigs at different ages. Prieto C. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred. Wei Z. Charoenchanikran P. Health Prod.
Sirisereewan C. Madapong A. Nodelijk G. A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Chen N. Emergence of novel European genotype porcine reproductive and respiratory syndrome virus in mainland China. Choi K. Comparison of the pathogenesis of single or dual infections with type 1 and type 2 porcine reproductive and respiratory syndrome virus.
Kang I. Improved growth performance by type 2 porcine reproductive and respiratory syndrome virus PRRSV -based modified live vaccine in a herd with concurrent circulation of type 1 and type 2 PRRSV. Comparison of growth performance under field conditions in growing pigs each vaccinated with one of two commercial modified-live porcine reproductive and respiratory syndrome vaccines. Swine Health Prod. Kristensen C.
Simplicity of administration to ensure compliance. Based on these set criteria we believe that PRRS-RP technology not only has a potential significant advantage over traditional vaccines but also meets each of these requirements as a new effective PRRS vaccine.
The objective of the proposal is to show the PRRS-RP vaccine candidate is not only able to significantly reduce viremia but is safe and efficacious. We aim to accomplish this by; determining if vaccinated pigs shed PRRS-RP and if so do non-vaccinated co-mingled pigs become infected. In response to this data we will determine if a non-target species is capable of shedding the PRRS-RP and if so can it infect other comingled animals. These studies will position Harrisvaccines, Inc.
Skip to main content. You are here Home.
0コメント